EMA AI Tool Qualification: How the AIM-NASH App...

By Rene Pretorius

May 19, 2025

The European Medicines Agency (EMA) has issued its first Qualification Opinion (QO) for an
Publication Delays Impact Careers of Early-Career Researchers
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US
EFPIA Advocates for Stronger Life Sciences in EU Multiannual Financial Framework
Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives a...
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
VIETNARMS Trial Unveils Innovative Hepatitis C Treatment Options
Revolutionizing Hepatitis C Treatment: The Transformative Role of Direct-Acti...
Hepatitis C Investment Impact: Maximizing Health and Economic Returns in China
First At-Home HPV Testing Approval: FDA Clears Teal Wand
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
Prevention Valuation: Fund Health, Not Just Savings